Anna L. Mitchell

CTLA-4 as a genetic determinant in autoimmune Addison’s disease

K. Badenhoop, H. Cordell, D. Undlien, 2015, Genes and Immunity.

Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility.

H. Cordell, S. Pearce, E. Husebye, 2009, The Journal of clinical endocrinology and metabolism.

Role of the X-linked gene GPR174 in autoimmune Addison's disease.

S. Pearce, A. Mitchell, E. Gan, 2015, The Journal of clinical endocrinology and metabolism.

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement

L. Hegedüs, W. Wiersinga, P. Perros, 2017, Orphanet Journal of Rare Diseases.

Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement.

W. Wiersinga, G. Kahaly, M. Ludgate, 2015, Thyroid : official journal of the American Thyroid Association.

Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit

P. Perros, J. Lazarus, C. MacEwen, 2017, Orbit.